Mark Sieczkarek is listed as an executive officer and director on 14 SEC Form D filings by 4 issuers between Jan 2010 and Jan 2022: NovaBay Pharmaceuticals, Inc. (Emeryville, CA — industry reported as "Other" — 2015–2019; $134M reported sold to 21 investors), SOLTA MEDICAL INC (Hayward, CA — other health care — 2010–2013; $25.5M reported sold to 173 investors), OT Global, LLC (El Segundo, CA — industry reported as "Other" — 2018–2022; $425K reported sold to 4 investors) and Orange Twist LLC (El Segundo, CA — other health care — 2020; $190K reported sold to 4 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $160.1M sold in total.
Listed alongside Clint Carnell (7 shared filings), Gail Maderis (6 shared filings), PAUL FREIMAN (6 shared filings), Jared Smith (5 shared filings), JUSTIN HALL (4 shared filings) and 36 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
3 of the issuers belong to the sponsor group Solta (3 issuers, $25.7M reported sold, 2010–2022).
What this means A sponsor group is one team that sets up a new company for each deal. Solta has 3 companies on file and $25.7M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 14 public filings for Mark Sieczkarek and found 14 differences, 4 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.